Structure for inhibitor I32.005: survivin
 
| PDB | Organism | Resolution | Comment |
|---|---|---|---|
| 1E31 | Homo sapiens | 2.71 Å | dimer |
| One monomer of the dimer is shown. The structural zinc ion is shown as a light grey CPK sphere. The reactive site residue Asp71 is shown in ball-and-stick representation in pink | |||
![]() |
|||
| Show surface | |||
![]() |
|||
| TERTIARY STRUCTURE DATA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Comment | Resolution | PDB | PDBe | SCOP | CATH | PDBSum | Proteopedia | Reference |
| Homo sapiens | ||||||||
| dimer | 2.71 Å | 1E31 | 1E31 | 1E31 | 1E31 | 1E31 | 1E31 | Chantalat et al., 2000 |
| mature inhibitor | 2.58 Å | 1F3H | 1F3H | 1F3H | 1F3H | 1F3H | 1F3H | Verdecia et al., 2000 |
| NMR structure | 0.00 Å | 1XOX | 1XOX | 1XOX | 1XOX | 1XOX | 1XOX | Sun et al., 2005 |
| complex with borealin-incenp core | 1.40 Å | 2QFA | 2QFA | 2QFA | 2QFA | 2QFA | 2QFA | Jeyaprakash et al., 2007 |
| complex with borealin | 2.40 Å | 2RAW | 2RAW | 2RAW | 2RAW | 2RAW | 2RAW | Bourhis et al., 2007 |
| complex with borealin (20-78) | 3.30 Å | 2RAX | 2RAX | 2RAX | 2RAX | 2RAX | 2RAX | Bourhis et al., 2007 |
| crystal structure of human survivin bound to histone h3 phosphorylatedon threonine-3. | 2.18 Å | 3UEC | 3UEC | 3UEC | 3UEC | 3UEC | 3UEC | |
| bound to histone h3 phosphorylatedon threonine-3 (c2 space group). | 2.70 Å | 3UED | 3UED | 3UED | 3UED | 3UED | 3UED | |
| crystal structure of human survivin k62a mutant bound to n-terminal histone h3 | 2.61 Å | 3UEE | 3UEE | 3UEE | 3UEE | 3UEE | 3UEE | |
| crystal structure of human survivin bound to histone h3 (c2 space group). | 2.45 Å | 3UEF | 3UEF | 3UEF | 3UEF | 3UEF | 3UEF | |
| crystal structure of human survivin k62a mutant | 2.80 Å | 3UEG | 3UEG | 3UEG | 3UEG | 3UEG | 3UEG | |
| crystal structure of human survivin h80a mutant | 2.60 Å | 3UEH | 3UEH | 3UEH | 3UEH | 3UEH | 3UEH | |
| crystal structure of human survivin e65a mutant | 2.70 Å | 3UEI | 3UEI | 3UEI | 3UEI | 3UEI | 3UEI | |
| complex with t3 phosphorylated h3(1-15) peptide | 2.40 Å | 3UIG | 3UIG | 3UIG | 3UIG | 3UIG | 3UIG | |
| complex with smac/diablo(1-15) peptide | 2.40 Å | 3UIH | 3UIH | 3UIH | 3UIH | 3UIH | 3UIH | |
| complex with h3(1-10) peptide | 2.60 Å | 3UII | 3UII | 3UII | 3UII | 3UII | 3UII | |
| Lys62Tyr/His80Trp mutant; complex with smac/diablo(1-15) peptide | 2.71 Å | 3UIJ | 3UIJ | 3UIJ | 3UIJ | 3UIJ | 3UIJ | |
| Lys62Tyr/His80Trp mutant; complex with h3(1-10) peptide | 2.70 Å | 3UIK | 3UIK | 3UIK | 3UIK | 3UIK | 3UIK | |
| crystal structure of survivin bound to the n-terminal tail of hsgo1 | 2.60 Å | 4A0I | 4A0I | 4A0I | 4A0I | 4A0I | 4A0I | |
| crystal structure of survivin bound to the phosphorylated n- terminal tail of histone h3 | 2.80 Å | 4A0J | 4A0J | 4A0J | 4A0J | 4A0J | 4A0J | |
| crystal structure of survivin bound to the phosphorylated n- terminal tail of histone h3 | 2.74 Å | 4A0N | 4A0N | 4A0N | 4A0N | 4A0N | 4A0N | |
| Mus musculus | ||||||||
| mature inhibitor | 2.80 Å | 1M4M | 1M4M | 1M4M | 1M4M | 1M4M | 1M4M | Muchmore et al., 2000 |


